Free Trial

Cronos Group Inc. (NASDAQ:CRON) Short Interest Update

Cronos Group logo with Medical background

Cronos Group Inc. (NASDAQ:CRON - Get Free Report) was the recipient of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 3,900,000 shares, a decline of 20.7% from the October 15th total of 4,920,000 shares. Based on an average trading volume of 926,700 shares, the short-interest ratio is currently 4.2 days. Approximately 2.0% of the company's shares are short sold.

Institutional Trading of Cronos Group

Several large investors have recently modified their holdings of CRON. Tidal Investments LLC acquired a new stake in shares of Cronos Group during the 1st quarter valued at approximately $17,217,000. Mackenzie Financial Corp purchased a new stake in Cronos Group during the second quarter valued at about $3,237,000. Dimensional Fund Advisors LP lifted its stake in Cronos Group by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,631,783 shares of the company's stock worth $6,132,000 after acquiring an additional 192,469 shares in the last quarter. Intact Investment Management Inc. lifted its stake in shares of Cronos Group by 89.1% in the 3rd quarter. Intact Investment Management Inc. now owns 377,890 shares of the company's stock valued at $836,000 after purchasing an additional 178,100 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Cronos Group by 37.9% in the 2nd quarter. Renaissance Technologies LLC now owns 464,949 shares of the company's stock valued at $1,083,000 after acquiring an additional 127,753 shares in the last quarter. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Trading Down 2.9 %

Shares of Cronos Group stock traded down $0.06 during trading hours on Friday, reaching $2.01. 1,238,069 shares of the company's stock were exchanged, compared to its average volume of 1,932,468. The firm has a market capitalization of $768.42 million, a price-to-earnings ratio of -15.92 and a beta of 0.98. Cronos Group has a 52-week low of $1.85 and a 52-week high of $3.14. The company has a fifty day moving average of $2.17 and a 200-day moving average of $2.35.

Cronos Group Company Profile

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Cronos Group right now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines